FDA approves continuous glucose monitoring system

June 29, 2018

(HealthDay)—The Eversense Continuous Glucose Monitoring (CGM) system, which has a fully implantable sensor to detect glucose, has been approved by the U.S. Food and Drug Administration for use in people age 18 years and older with diabetes.

The Eversense CGM uses a small sensor, which is implanted just under the skin by a qualified health care provider. The sensor regularly measures in adults with diabetes for up to 90 days after implantation. The sensor works with a novel light-based to measure levels and alerts users via a message sent to a mobile app in cases of hyper- or hypoglycemia.

In order to review the device's effectiveness, the FDA assessed clinical study data from 125 individuals (aged 18 years and older) and compared readings obtained by the Eversense CGM with those obtained by a laboratory-based glucose analyzer. During the clinical studies, the safety of the CGM system's implantable sensor and the procedure used to implant it were also assessed. The proportion of individuals who experienced a serious adverse event was less than 1 percent. Approval of the Eversense CGM System was granted to Senseonics Inc.

"The FDA is committed to advancing novel products that leverage digital technology to improve patient care," FDA Commissioner Scott Gottlieb, M.D., said in a statement. "These technologies allow patients to gain better control over their health."

Explore further: Implanted continuous glucose sensor proven safe and accurate in types 1 and 2 diabetes

More information: More Information

Related Stories

Implanted continuous glucose sensor proven safe and accurate in types 1 and 2 diabetes

February 12, 2018
Results of the PRECISE II study showed the implanted continuous glucose monitoring (CGM) system from Eversense to be safe and highly accurate over the 90-day sensor life in patients with type 1 or type 2 diabetes. More than ...

Implantable continuous glucose monitoring system safe, accurate

November 14, 2016
(HealthDay)—A new implantable continuous glucose monitoring (CGM) system seems to be safe and accurate for diabetes, according to a study published online Nov. 4 in Diabetes Care.

Fitbit, Dexcom will provide self-management tool for glucose level monitoring

September 10, 2017
(Tech Xplore)—Self-care among people with diabetes is important along with self-monitoring of blood glucose levels. Yet medical problems can trouble some people if they do not manage their diabetes aggressively enough and ...

Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin

January 24, 2017
Two studies in the January 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple ...

Mini-dose glucagon may halt post-exercise hypoglycemia

May 30, 2018
(HealthDay)—Mini-dose glucagon (MDG) is an effective approach for preventing exercise-induced hypoglycemia in patients with type 1 diabetes, according to a study published online May 18 in Diabetes Care.

Dexcom wins FDA approval for next generation of glucose monitors for diabetes

April 6, 2018
San Diego's Dexcom has won regulatory approval for its latest continuous glucose monitoring system that eliminates the need for finger pricks and is nearly one-third smaller than its current wearable sensor for diabetes patients.

Recommended for you

Switching to certain antidiabetic drugs linked to increased risk of major complications

July 18, 2018
For people with type 2 diabetes, switching to sulfonylurea drugs to control blood sugar levels is associated with an increased risk of complications compared with staying on the drug metformin, finds a study in The BMJ today.

Researchers cure type 2 diabetes and obesity in mice using gene therapy

July 10, 2018
A research team from the UAB led by Professor Fatima Bosch has managed to cure obesity and type 2 diabetes in mice using gene therapy.

Human clinical trial reveals verapamil as an effective type 1 diabetes therapy

July 9, 2018
Researchers at the University of Alabama at Birmingham Comprehensive Diabetes Center have discovered a safe and effective novel therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent ...

New targets found to reduce blood vessel damage in diabetes

July 9, 2018
In diabetes, both the tightly woven endothelial cells that line our blood vessels and the powerhouses that drive those cells start to come apart as early steps in the destruction of our vasculature.

Insurance gaps linked to five-fold rise in hospital stays for adults with type 1 diabetes

July 9, 2018
For a million American adults, living with type 1 diabetes means a constant need for insulin medication, blood sugar testing supplies and specialized care, to keep them healthy and prevent a crisis that could end up in an ...

Abnormal branched-chain amino acid breakdown may raise diabetes risk

July 5, 2018
In the U.S., about five out of 100 expectant mothers develop gestational diabetes mellitus (GDM), a temporary form of diabetes in which hormonal changes disrupt insulin function. Although GDM is often symptomless and subsides ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.